News

News

College health insurer Wellfleet teams up with binx health to keep students safe and campuses open in the fight against COVID-19

Wellfleet taps binx for convenient, in-dorm sample collection and bespoke technology solutions to help arrest virus spread

binx io with COVID-19 cartridge
News

Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19

binx health’s Proven Molecular io Platform Combined with SHERLOCK™ CRISPR Technology Will Enable Rapid, Accurate Testing for SARS-CoV-2 in Retail and Near-patient Settings

News

binx health and UPS Jointly Announce International Partnership for At-home “Contactless” COVID-19 Sample Collection

Binx and UPS Healthcare pair advanced infectious disease testing with superior global logistics to reach populations everywhere, starting in the United Kingdom

News

binx health Announces Publication of Pivotal Study in JAMA Network Open

Study signals “real paradigm shift” in care resulting from the world’s first FDA-cleared, 30-minute, molecular point-of-care platform for the detection of chlamydia and gonorrhea

News

binx health Announces Second FDA 510(k) Clearance of its Molecular Point-of-Care Infectious Disease Platform

Latest FDA clearance establishes binx as the fastest dual-gender rapid test-and-treat platform for chlamydia and gonorrhea

COVID-19 pandemic has created growing backlog of millions in need of routine STI testing

News

Fortune Magazine featured binx health’s io as a healthcare “breakthrough,” as it expands access to high quality chlamydia and gonorrhea testing at point of care sites across the US

binx health was featured in Fortune Magazine highlighting the io platform as not only the first and fastest FDA-cleared molecular point-of-care diagnostic for the detection of chlamydia and gonorrhea, but…

News

Given market demand, binx health announces launch of pre-order program for its first-of-kind rapid, molecular point-of-care platform

binx offers first FDA 510(k) cleared molecular point-of-care solution for test and treat of sexually-transmitted infections in a single visit

News

binx health To Present At The Canaccord Genuity Medical Technology and Diagnostics Forum

binx health, the pioneer in anywhere, anytime testing for women’s health, today announced that Jeffrey Luber, president and CEO is scheduled to present on Thursday, November 21, 2019 at 11:00…

Placing STI cartridge into POC Desktop Instrument
News

binx health Announces First Patients Benefiting from Single-Visit Test and Treatment for Chlamydia and Gonorrhea

binx FDA-cleared platform already impacting human health—poised to transform care for millions